feed,title,long_url,short_url
Benzinga,Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC,https://benzinga.com/general/biotech/21/06/21613101/biden-administration-devotes-over-3-2b-for-development-of-oral-antiviral-therapies-for-covid-19-c,https://j.mp/2SbbUfK
